Page last updated: 2024-08-23

buserelin and Invasiveness, Neoplasm

buserelin has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar-Rojas, A; Arechavaleta-Velásco, F; Conn, PM; Huerta-Reyes, M; Maya-Núñez, G; Ulloa-Aguirre, A; Valdés, J1

Other Studies

1 other study(ies) available for buserelin and Invasiveness, Neoplasm

ArticleYear
Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
    BMC cancer, 2012, Nov-23, Volume: 12

    Topics: Actins; Breast Neoplasms; Buserelin; Cell Line, Tumor; Cell Movement; Enzyme Activation; Female; Flow Cytometry; Fluorometry; Focal Adhesions; Gonadotropin-Releasing Hormone; Humans; Immunoblotting; MCF-7 Cells; Microscopy, Confocal; Mutation; Neoplasm Invasiveness; Polymerization; Receptors, LHRH; rhoA GTP-Binding Protein; Stress Fibers; Transfection

2012